Peter Olagunju

Insider Reports History

Entity
Individual
Location
Tcr2 Therapeutics Inc., 100 Binney Street, Suite 710, Cambridge, MA
Signature
/s/ Margaret Siegel as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Olagunju:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TCR2 THERAPEUTICS INC. Chief Operating Officer Common Stock 0 $1.72 Jun 1, 2023 Direct
TCR2 THERAPEUTICS INC. Chief Operating Officer Restricted Stock Unit 0 Jun 1, 2023 Direct
TCR2 THERAPEUTICS INC. Chief Operating Officer Stock Option (Right to Buy) 0 $0.74 Jun 1, 2023 Direct

Insider Reports Filed by Peter Olagunju

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TCRR TCR2 THERAPEUTICS INC. Jun 1, 2023 5 $0 4 Jun 1, 2023 Chief Operating Officer
TCRR TCR2 THERAPEUTICS INC. Dec 15, 2022 2 $0 4 Dec 19, 2022 Chief Technical Officer
TCRR TCR2 THERAPEUTICS INC. Dec 9, 2022 3 -$5.3K 4 Dec 13, 2022 Chief Technical Officer
TCRR TCR2 THERAPEUTICS INC. Dec 7, 2022 2 -$3.53K 4 Dec 9, 2022 Chief Technical Officer
TCRR TCR2 THERAPEUTICS INC. Dec 5, 2022 2 -$3.53K 4 Dec 7, 2022 Chief Technical Officer
TCRR TCR2 THERAPEUTICS INC. Dec 1, 2022 3 -$1.77K 4 Dec 5, 2022 Chief Technical Officer
TCRR TCR2 THERAPEUTICS INC. Nov 17, 2022 4 $0 4 Nov 18, 2022 Chief Technical Officer
TCRR TCR2 THERAPEUTICS INC. Dec 9, 2021 1 $0 4 Dec 10, 2021 Chief Technical Officer
TCRR TCR2 THERAPEUTICS INC. Jul 26, 2021 1 $0 4 Jul 27, 2021 Chief Technical Officer
TCRR TCR2 THERAPEUTICS INC. Jul 26, 2021 0 $0 3 Jul 27, 2021 Chief Technical Officer